跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
FLURESS
Authorized
STANDARD
FLURESS
Akorn Inc
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
4925a85725a514b4
Company
Akorn Inc
Type
Standard
Approval Details
Approval Id
4925a85725a514b4
Drug Approval Canada Name
FLURESS
Product Name
FLURESS
Status
Cancelled Post Market
Status Date
2021-03-01
Original Market Date
1996-12-18
Din
02216728
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
ETHICAL
Ahfs
36:58.00 , 52:16.00
Atc Original
S01JA51 FLUORESCEIN, COMBINATIONS
Aig Number
0207547001
Company Name
Akorn Inc
Company Address
300 1925 West Field Ct Lake Forest Illinois United States 60045
Company Detail Path
/organization/akorn-inc-arlington-massachusetts-united-states
Company Information
Pharmaceutical Company Name
Akorn Inc
Country Name
United States
Province Name
Massachusetts
City Name
arlington,massachusetts,country_us
Address
13A Medford St
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
4925a85725a514b4
Type
Standard
Back to Health Canada Approvals
FLURESS - Health Canada Drug Approval Details